-
1
-
-
29944444165
-
Acute and long-term safety and tolerability of risperidone in children with autism
-
16379507 10.1089/cap.2005.15.869
-
Aman, M. G.; Arnold, L. E.; McDougle, C. J.; Vitiello, B.; Scahill, L.; Davies, M.; et al. (2005). Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology, 15(6), 869-884.
-
(2005)
Journal of Child and Adolescent Psychopharmacology
, vol.15
, Issue.6
, pp. 869-884
-
-
Aman, M.G.1
Arnold, L.E.2
McDougle, C.J.3
Vitiello, B.4
Scahill, L.5
Davies, M.6
-
2
-
-
84880309054
-
-
manual East Aurora, NY: Slosson Educational Publication
-
Aman, M. G.; & Singh, N. N. (1994). Aberrant behavior checklist - community. (supplementary manual). East Aurora, NY: Slosson Educational Publication.
-
(1994)
Aberrant Behavior Checklist Community
, Issue.SUPPL.
-
-
Aman, M.G.1
Singh, N.N.2
-
3
-
-
0022003626
-
The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects
-
3993694
-
Aman, M. G.; Singh, N. N.; Stewart, A. W.; & Field, C. J. (1985a). The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485-491.
-
(1985)
American Journal of Mental Deficiency
, vol.89
, Issue.5
, pp. 485-491
-
-
Aman, M.G.1
Singh, N.N.2
Stewart, A.W.3
Field, C.J.4
-
4
-
-
0021916021
-
Psychometric characteristics of the Aberrant Behavior Checklist
-
3158201
-
Aman, M. G.; Singh, N. N.; Stewart, A. W.; & Field, C. J. (1985b). Psychometric characteristics of the Aberrant Behavior Checklist. American Journal of Mental Deficiency, 89(5), 492-502.
-
(1985)
American Journal of Mental Deficiency
, vol.89
, Issue.5
, pp. 492-502
-
-
Aman, M.G.1
Singh, N.N.2
Stewart, A.W.3
Field, C.J.4
-
5
-
-
34548349337
-
Plasma pharmacokinetics characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorder
-
17825699 10.1016/j.clinthera.2007.07.026
-
Aman, M. G.; Vinks, A. A.; Remmerie, B.; Mannaert, E.; Ramadan, Y.; Masty, J.; et al. (2007). Plasma pharmacokinetics characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorder. Clinical Therapeutics, 29, 1476-1486.
-
(2007)
Clinical Therapeutics
, vol.29
, pp. 1476-1486
-
-
Aman, M.G.1
Vinks, A.A.2
Remmerie, B.3
Mannaert, E.4
Ramadan, Y.5
Masty, J.6
-
6
-
-
33846562907
-
Effect of short- and long-term risperidone treatment on prolactin levels in children with autism
-
16730335 10.1016/j.biopsych.2006.02.032
-
Anderson, G. M.; Scahill, L.; McCracken, J. T.; McDougle, C. J.; Aman, M. G.; Tierney, E.; et al. (2007). Effect of short- and long-term risperidone treatment on prolactin levels in children with autism. Biological Psychiatry, 61(4), 545-550.
-
(2007)
Biological Psychiatry
, vol.61
, Issue.4
, pp. 545-550
-
-
Anderson, G.M.1
Scahill, L.2
McCracken, J.T.3
McDougle, C.J.4
Aman, M.G.5
Tierney, E.6
-
7
-
-
0642303695
-
Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials
-
14627879 10.1097/00004583-200312000-00011
-
Arnold, L. E.; Vitiello, B.; Mcdougle, C.; Scahill, L.; Shah, B.; Gonzalez, N. M.; et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1443-1450.
-
(2003)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.42
, Issue.12
, pp. 1443-1450
-
-
Arnold, L.E.1
Vitiello, B.2
McDougle, C.3
Scahill, L.4
Shah, B.5
Gonzalez, N.M.6
-
8
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
2574607 10.1192/bjp.154.5.672
-
Barnes, T. R. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672-676.
-
(1989)
British Journal of Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.R.1
-
9
-
-
0344119561
-
Prolactin levels during long-term risperidone treatment in children and adolescents
-
14658952 10.4088/JCP.v64n1113
-
Findling, R. L.; Kusumakar, V.; Daneman, D.; Moshang, T.; De Smedt, G.; & Binder, C. (2003). Prolactin levels during long-term risperidone treatment in children and adolescents. Journal of Clinical Psychiatry, 64(11), 1362-1369.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.11
, pp. 1362-1369
-
-
Findling, R.L.1
Kusumakar, V.2
Daneman, D.3
Moshang, T.4
De Smedt, G.5
Binder, C.6
-
10
-
-
33845797961
-
The genetics of autistic disorders and its clinical relevance: A review of the literature
-
17033636 10.1038/sj.mp.4001896
-
Freitag, C. M. (2007). The genetics of autistic disorders and its clinical relevance: A review of the literature. Molecular Psychiatry, 12(1), 2-22.
-
(2007)
Molecular Psychiatry
, vol.12
, Issue.1
, pp. 2-22
-
-
Freitag, C.M.1
-
11
-
-
1942507408
-
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications
-
15142390 10.1089/104454604773840472
-
Gagliano, A.; Germano, E.; Pustorino, G.; Impallomeni, C.; D'arrigo, C.; Calamoneri, F.; et al. (2004). Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications. Journal of Child and Adolescent Psychopharmacology, 14(1), 39-47.
-
(2004)
Journal of Child and Adolescent Psychopharmacology
, vol.14
, Issue.1
, pp. 39-47
-
-
Gagliano, A.1
Germano, E.2
Pustorino, G.3
Impallomeni, C.4
D'Arrigo, C.5
Calamoneri, F.6
-
14
-
-
16244384219
-
Review: Autistic disorder and viral infections
-
15804954 10.1080/13550280590900553
-
Libbey, J. E.; Sweeten, T. L.; McMahon, W. M.; & Fujinami, R. S. (2005). Review: Autistic disorder and viral infections. Journal of Neurovirology, 11, 1-10.
-
(2005)
Journal of Neurovirology
, vol.11
, pp. 1-10
-
-
Libbey, J.E.1
Sweeten, T.L.2
McMahon, W.M.3
Fujinami, R.S.4
-
15
-
-
29144501680
-
Metabolic changes associated with antipsychotic use. Prim Care Campanion
-
Lieberman, J. A. (2004). Metabolic changes associated with antipsychotic use. Prim Care Campanion. Journal of Clinical Psychiatry, 6(2), 8-13.
-
(2004)
Journal of Clinical Psychiatry
, vol.6
, Issue.2
, pp. 8-13
-
-
Lieberman, J.A.1
-
16
-
-
34548383985
-
Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors?
-
17766532 10.1542/peds.2007-1041
-
Limperopoulos, C.; Bassan, H.; Gauvreau, K.; Robertson, R. L.; Jr, Sullivan, N. R.; Benson, C. B.; et al. (2007). Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors? Pediatrics, 120(3), 584-593.
-
(2007)
Pediatrics
, vol.120
, Issue.3
, pp. 584-593
-
-
Limperopoulos, C.1
Bassan, H.2
Gauvreau, K.3
Robertson, Jr.R.L.4
Sullivan, N.R.5
Benson, C.B.6
-
17
-
-
0036479943
-
Risperidone treatment in children and adolescents with autism: Short- and long-term safety and effectiveness
-
11837403 10.1097/00004583-200202000-00007
-
Malone, R. P.; Maislin, G.; Choudhury, M. S.; Gifford, C.; & Delaney, M. A. (2002). Risperidone treatment in children and adolescents with autism: Short- and long-term safety and effectiveness. Journal of the American Academy of Child and Adolescent Psychiatry, 41(2), 140-147.
-
(2002)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.41
, Issue.2
, pp. 140-147
-
-
Malone, R.P.1
Maislin, G.2
Choudhury, M.S.3
Gifford, C.4
Delaney, M.A.5
-
18
-
-
0037257613
-
Treatment of aggression in children and adolescent with autism and conduct disorder
-
Mc Dougle, C. J.; Stigler, K. A.; & Posey, D. J. (2003). Treatment of aggression in children and adolescent with autism and conduct disorder. Journal of Clinical Psychiatry, 64(4), 16-25.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.4
, pp. 16-25
-
-
Mc Dougle, C.J.1
Stigler, K.A.2
Posey, D.J.3
-
19
-
-
0036682267
-
Risperidone in children with autism and serious behavioral problems
-
12151468 10.1056/NEJMoa013171
-
McCracken, J. T.; Mcgough, J.; Shah, B.; Cronin, P.; Hong, D.; Aman, M. G.; et al. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347(5), 314-321.
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.5
, pp. 314-321
-
-
McCracken, J.T.1
McGough, J.2
Shah, B.3
Cronin, P.4
Hong, D.5
Aman, M.G.6
-
20
-
-
0031968207
-
An open trial of risperidone in young autistic children
-
9549957 10.1097/00004583-199804000-00014
-
Nicolson, R.; Awad, G.; & Sloman, L. (1998). An open trial of risperidone in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 37(4), 372-376.
-
(1998)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.37
, Issue.4
, pp. 372-376
-
-
Nicolson, R.1
Awad, G.2
Sloman, L.3
-
21
-
-
33847221134
-
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial
-
17019624 10.1007/s10803-006-0234-7
-
Pandina, G. J.; Bossie, C. A.; Youssef, E.; Zhu, Y.; & Dunbar, F. (2007). Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. Journal of Autism and Developmental Disorders, 37(2), 367-373.
-
(2007)
Journal of Autism and Developmental Disorders
, vol.37
, Issue.2
, pp. 367-373
-
-
Pandina, G.J.1
Bossie, C.A.2
Youssef, E.3
Zhu, Y.4
Dunbar, F.5
-
22
-
-
33746314832
-
Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues
-
16808981 10.1016/j.tins.2006.05.010
-
Persico, A. M.; & Bourgeron, T. (2006). Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends in Neurosciences, 29(7), 349-358.
-
(2006)
Trends in Neurosciences
, vol.29
, Issue.7
, pp. 349-358
-
-
Persico, A.M.1
Bourgeron, T.2
-
23
-
-
33645905430
-
A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders
-
16513860 10.1176/appi.ajp.163.3.402
-
Reyes, M.; Buitelaar, J.; Toren, P.; Augustyns, I.; & Eerdekens, M. (2006). A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. American Journal of Psychiatry, 163, 402-410.
-
(2006)
American Journal of Psychiatry
, vol.163
, pp. 402-410
-
-
Reyes, M.1
Buitelaar, J.2
Toren, P.3
Augustyns, I.4
Eerdekens, M.5
-
24
-
-
84880268702
-
-
Risperdal® Prescribing Information (revised 2012)
-
Risperdal® Prescribing Information (revised 2012). http://www.accessdata.fda.gov/drugsatfda-docs/label/2012/020272s065,020588s053, 021444s041lbl.pdf.
-
-
-
-
25
-
-
21344434103
-
Research units on pediatric psychopharmacology autism network. Risperidone treatment of autistic disorder: Longer-term benefits and blinded discontinuation after 6 months
-
RUPP 10.1176/appi.ajp.162.7.1361
-
RUPP. (2005). Research units on pediatric psychopharmacology autism network. Risperidone treatment of autistic disorder: Longer-term benefits and blinded discontinuation after 6 months. American Journal of Psychiatry, 162, 1361-1369.
-
(2005)
American Journal of Psychiatry
, vol.162
, pp. 1361-1369
-
-
-
26
-
-
0030916657
-
Children's yale-brown obsessive compulsive scale: Reliability and validity
-
9183141 10.1097/00004583-199706000-00023
-
Scahill, L.; Riddle, M. A.; McSwiggin-Hardin, M.; Ort, S. I.; King, R. A.; Goodman, W. K.; et al. (1997). Children's yale-brown obsessive compulsive scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844-852.
-
(1997)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.36
, Issue.6
, pp. 844-852
-
-
Scahill, L.1
Riddle, M.A.2
McSwiggin-Hardin, M.3
Ort, S.I.4
King, R.A.5
Goodman, W.K.6
-
27
-
-
14644396233
-
Developmental deficits in social perception in autism: The role of the amygdala and fusiform face area
-
10.1016/j.ijdevneu.2004.12.012
-
Schultz, R. T. (2005). Developmental deficits in social perception in autism: The role of the amygdala and fusiform face area. International Society for Developmental Neuroscience, 23, 125-141.
-
(2005)
International Society for Developmental Neuroscience
, vol.23
, pp. 125-141
-
-
Schultz, R.T.1
-
28
-
-
16644370679
-
Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
-
15492353 10.1542/peds.2003-0264-F
-
Shea, S.; Turgay, A.; Carroll, A.; Schulz, M.; Orlik, H.; Smith, I.; et al. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114(5), e634-e641.
-
(2004)
Pediatrics
, vol.114
, Issue.5
-
-
Shea, S.1
Turgay, A.2
Carroll, A.3
Schulz, M.4
Orlik, H.5
Smith, I.6
-
30
-
-
33745805381
-
Tracing the origins of autism: A spectrum of new studies
-
16835042 10.1289/ehp.114-a412
-
Szpir, M. (2006). Tracing the origins of autism: A spectrum of new studies. Environmental Health Perspectives, 114(7), A412-A418.
-
(2006)
Environmental Health Perspectives
, vol.114
, Issue.7
-
-
Szpir, M.1
-
31
-
-
77953333906
-
Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders
-
20528007 10.2165/11531730-000000000-00000
-
Thyssen, A.; Vermeulen, A.; Fuseau, E.; Fabre, M.; & Mannaert, E. (2010). Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders. Clinical Pharmacokinetics, 49(7), 465-478.
-
(2010)
Clinical Pharmacokinetics
, vol.49
, Issue.7
, pp. 465-478
-
-
Thyssen, A.1
Vermeulen, A.2
Fuseau, E.3
Fabre, M.4
Mannaert, E.5
-
32
-
-
27144532065
-
Long-trem effects of risperidone in children with autism spectrum disorders: A placebo discontinuation study
-
16239862 10.1097/01.chi.0000177055.11229.76
-
Troost, P. W.; Lahuis, B. E.; Steenhuis, M. P.; Ketelaars, C. E. J.; Buitelaar, J. K.; & Van England, H. (2005). Long-trem effects of risperidone in children with autism spectrum disorders: A placebo discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 44(11), 1137-1144.
-
(2005)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.44
, Issue.11
, pp. 1137-1144
-
-
Troost, P.W.1
Lahuis, B.E.2
Steenhuis, M.P.3
Ketelaars, C.E.J.4
Buitelaar, J.K.5
Van England, H.6
-
33
-
-
34447341958
-
Review: Metabolic side effect of antipsychotic medication
-
17627711 10.1111/j.1742-1241.2007.01416.x
-
Tschoner, A.; Engl, J.; Lamier, M.; Kaser, S.; Rettenbacher, M.; Fleischhacker, J. R.; et al. (2007). Review: Metabolic side effect of antipsychotic medication. International Journal of Clinical Practice, 61(8), 1356-1370.
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.8
, pp. 1356-1370
-
-
Tschoner, A.1
Engl, J.2
Lamier, M.3
Kaser, S.4
Rettenbacher, M.5
Fleischhacker, J.R.6
-
34
-
-
0036718143
-
Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs
-
10.1542/peds.110.3.e34
-
Turgay, A.; Binder, C.; Snyder, R.; & Fisman, S. (2002). Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics, 110(3), 1-12.
-
(2002)
Pediatrics
, vol.110
, Issue.3
, pp. 1-12
-
-
Turgay, A.1
Binder, C.2
Snyder, R.3
Fisman, S.4
|